Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Various substances, quitting smoking, and certain topical applications can enhance the survival of skin flaps used in surgery. Oxygen-free radicals play a role in tissue injury, but certain treatments can have beneficial effects.

Fetuin-A helps wounds heal without scars by promoting cell movement.

White oyster mushroom extracts may help dissolve blood clots.

A woman lost vision in one eye after a forehead injection, but prompt treatment led to partial vision recovery.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Angio PRP speeds up skin wound healing by improving cell growth and blood vessel formation.

TTT speeds up diabetic wound healing by mobilizing specific immune cells.

The EG7 foam dressing improved wound healing and reduced inflammation better than other treatments.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

The new filler effectively and safely improves tear trough deformity long-term.

JAK inhibitors can help some people with long-standing alopecia areata regrow hair, but many stop treatment due to limited effectiveness.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tofacitinib treatment is used for teenagers with alopecia areata.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.